[The cerucal treatment of patients with hypomotoric gastroduodenal dyskinesias and dystonias].
Of 172 patients with gastroenterological diseases hypomotoric dyskinesias and dystonias were observed in 82 (48%). In 25% of patients cerucal did not produce any positive effect in gastric and duodenal hypokinesia. They were patients with leading parasympathetic activity and increase muscle tone with resulting reduced contraction amplitude ("false" hypokinesia), abnormal contraction phase modes, increased intracavitary pressure.
Reshetilov
Iu I
IuI
D002908:Chronic Disease; D004341:Drug Evaluation; D004378:Duodenal Diseases / Q000188:drug therapy* / Q000503:physiopathology; D004386:Duodenum / Q000187:drug effects / Q000503:physiopathology; D005769:Gastrointestinal Motility / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use*; D013270:Stomach / Q000187:drug effects / Q000503:physiopathology; D013272:Stomach Diseases / Q000188:drug therapy* / Q000503:physiopathology
D008787:Metoclopramide
Lechenie tserukalom bol'nykh s gipomotornymi gastroduodenal'nymi diskineziiami i distoniiami.